Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
SynAct Pharma AB
AB
Active
Org 5590584826
Scheelevägen 2, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 10 years old
5-9 ansatte
Overvåg
Share
Sverige
/
Virksomheder
/
Research and experimental development on natural sciences and engineering
/
SynAct Pharma AB
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Regnskaber
Revenue
SEK millions
10M
8M
5M
3M
0M
2M
2021
5M
+150%
2022
8M
+60%
2023
7M
-12%
2024
7M
0%
2025
EBITDA
SEK millions
0M
-7M
-14M
-22M
-29M
-11M
2021
-21M
-91%
2022
-23M
-10%
2023
-22M
+4%
2024
-13M
+41%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 637
5 144
8 262
6 969
6 839
Staff expenses
—
—
—
—
—
EBITDA
−10 962
−20 671
−23 018
−22 359
−13 115
Depreciation & amort.
−0
—
—
—
—
EBIT
−10 962
−20 671
−23 018
−22 359
−13 115
Net financials
−50 010
−111 420
−126 510
−70 310
−85 030
Profit before tax
−60 966
−130 970
−149 529
−90 623
−98 144
Tax
−0
−0
−0
−0
−0
Net profit
−60 966
−130 970
−149 529
−90 623
−98 144
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
45 334
119 225
230 768
257 757
230 217
Equity
40 404
111 127
214 072
241 360
216 293
Long-term debt
0
0
8 821
8 304
10 606
Short-term debt
4 930
8 098
7 876
8 093
3 318
Total debt
4 930
8 098
16 697
16 397
13 924
Financial ratios
5-year trend
EBITDA-margin
-191.8%
Denne virksomhed
15.8%
Markedsmedian
1314% under markedet
2021
2025
Soliditetsgrad
94.0%
Denne virksomhed
38.2%
Markedsmedian
146% over markedet
2021
2025
Egenkapitalforrentning
-45.4%
Denne virksomhed
18.4%
Markedsmedian
347% under markedet
2021
2025
Nettoresultatgrad
-1435.1%
Denne virksomhed
8.1%
Markedsmedian
17817% under markedet
2021
2025
Aktivomsætning
0.03×
Denne virksomhed
1.12×
Markedsmedian
97% under markedet
2021
2025
Gæld/egenkapital
0.06×
Denne virksomhed
0.62×
Markedsmedian
90% under markedet
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Mere om SynAct Pharma AB
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Personer & ejerskab →
Ledelse, bestyrelse og ejerfordeling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk
